Analysis of the US Neurovascular Intervention Market

Large Opportunities in Expanding Treatment Options and New Technologies

NC3F-54
July 2013

Executive Summary

NC3F-54

Executive Summary
Total revenue generated by sales of neurovascular intervention market in the US in
2012 was approximately $273.0 million.
Revenue in the US neurovascular intervention market is projected to grow at a
compound annual growth rate (CAGR) of 7.6 percent from 2012 to 2017, reaching
$392.8 million in 2017.
Currently, the largest market segment is the neurovascular coils market, while the
smallest is the liquid embolics market.
The segment with the highest CAGR is the stent retriever market, since the first stent
retriever in the US was launched in early 2012. More stent retrievers are expected to
enter the US market in the coming years.
The high growth rate in the stent retriever market is likely to offset the trends in the
relatively stable coils and liquid embolics markets, leading to the growth of the overall
neurovascular intervention market.
Source: Frost & Sullivan
NC3F-54

Executive Summary (continued)

There is great uncertainty surrounding the future of the neurovascular coils segment
because of emerging flow-diversion devices potential to become both a complement
and a substitute to coils for aneurysm treatment.
The US liquid embolics segment is essentially a monopoly as the Food and Drug
Administration (FDA) has placed the only product available under very restricted use
for fewer than 4,000 patients in the US.
Ischemic stroke patients had been previously underserved with only one treatment
option; thus, companies are now eager to develop and introduce stent retrievers to the
US market with a large patient base and high growth potential.
The overall US neurovascular intervention market is very concentrated with only a few
large manufacturers because of high barriers to entry, most notably the 510(k)
clearance required from the US FDA.

Source: Frost & Sullivan

NC3F-54

Executive SummaryMarket Engineering Measurements

Total Neurovascular Intervention Market: US, 2012

Market Overview
Market Stage

Market Revenue

$273.0 M

Growth

Market
Units/Volume

Compound
Annual Growth
Rate

7.6%

24.6%

(CAGR, 20122017)

Stable

$2,890.9

$392.8

(2012)

Base Year
Market Growth
Rate

Decreasing

Average Price*

174,257

(2012)

Market Size for

Last Year of
Study Period

Increasing

(2017)

Customer Price
Sensitivity

Degree of
Technical
Change

(scale:1 [Low] to 10 [High])

(scale:1 [Low] to 10 [High])

For a tabular version click here.

*Weighted Average Selling Price
Note: All figures are rounded. The base year is 2012. Source: Frost & Sullivan

NC3F-54

Executive SummaryMarket Engineering Measurements

(continued)

Industry Advancement

Competitor Overview
Number of
Competitors*

About 10
(active market competitors in
base year)

Decreasing

Stable

Number of
Companies that
Entered

Average
Product
Development
Time

5
Years

(2012)

Increasing
*About 10 with revenue greater than $1.0 million USD
Note: All figures are rounded. The base year is 2012. Source: Frost & Sullivan

NC3F-54

Executive SummaryCEOs Perspective

Rising ischemic stroke prevalence

represents a largely unpenetrated
market for solution providers.

Shorter recovery time for products like

liquid embolics is an attractive option
for hospitals looking to cut costs.

Growth through mergers and

acquisitions is a growing trend to
acquire niche technologies.

Published data on new clinical trials will

motivate physicians and surgeons to
use new methods of treatment.

Flow diversion devices are a looming

threat to the coils market, due to their
benefits in wide-neck aneurysms.
Source: Frost & Sullivan

NC3F-54